维普中文期刊产品整合服务
122篇 您的检索式:作者名="Multiple"
    题名 作者 年代 出处 被引量
1青海省岩石地层单位概要显示文摘分三个部分对青海省岩石地层单位进行概要介绍。第一部分是建议采用的岩石地层单位(包括顺序号、单位名称、代号、地质年代、资料卡片号与现在定义);第二部分是建议采用的岩石地层单位名称索引(一)、(二);第三部分是建议不采用的地层单位名称。为方便读者查找,文前附有编辑说明。Reseach group of stratigraphic multiple division and correlation,Qinghai Province 1995青海地质1995,4,1:7
2医院门诊药房与医院分离的理性探讨显示文摘介绍了医药分业的定义、国外医药分业的目的和少数医院无门诊药房的原因。指出门诊药房从医院分离出去弊大于利,认为门诊药房从医院分离,难以达到预期目的,反而有损于医疗卫生事业的公益性;医药分离削弱、甚至取消了医院对医师不当处方和合理药物治疗等医疗行为的行政和技术监管与干预;医药分离不适合我国的国情,不符合我国卫生体制改革的精神,不利于医疗质量的提高,不利于病人安全、有效、经济用药,不利于调动医院广大药学技术人员的积极性,不利于医院药物治疗管理自动化的实现与信息的传递。建议医药结合的模式必须加强;保留门诊药房,加大监督力度;建立药品配送中心,完善社会化物流机制;加速非处方药药品的发展;在条件成熟后实施处方调剂费;高薪养廉,较大幅度提高医师职业的收入;解决当前医疗体系中分配不合理问题,适当提高挂号、手术、诊疗等收费标准,降低药品收入在医院总收入中所占的比例。Pharmacy Administration Commision of CHA, Multiple Functions Building, Tiantan Hospital, 6 Tiantanxili, Chongwen District, Beijing City, 100853.PRC 2003中国医院2003,7,4:4
3Motor reactions显示文摘Zbinden A m Petersen-Felix S Thompson D A Anesthetic depth defined using multiple noxious stimuli during iso fluranee/oxygen anesthesia: T 1994Anesthesiology1994,80,:1
4Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial显示文摘 1995Neurology1995,45,7:1
5A retrospective muhicenter study 显示文摘Fassas A A Passweg J R Anagnostopoulos transplantation Hematopoietic stem cell for multiple sclerosis 2002J Neurol2002,249,8:1
6Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci显示文摘International Multiple Sclerosis Genetics Consortium (IMSGC) 2010Hum Mol Genet2010,19,:1
7Bad data identification for state estimation by combinatorial optimization显示文摘Monticelli A Wu F F Multiple M Y 1986IEEE Transactions on Power Delivery1986,1,3:1
8显示文摘 Picton TW Auditory steady-state responses to multiple simultaneous stimuli 1995Electroencephalogr Clin Neurophsil1995,96,:1
9Interferon beta-1b in the treatment of multiple sclerosis:final outcome of the randomized controlled trial显示文摘The IFNβ Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group 1995Neurology1995,45,7:1
10Bad data identifi- cation for state estimation by combinatorial optimization 显示文摘Monticelli A Wu F F Multiple M Y 1986IEEE Transactions on Power Delivery1986,1,3:1
11Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/ remitting multiple sclerosis显示文摘PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group 1998Lancet1998,352,9139:1
12, a critical role of IRF-I显示文摘JARUGA B HONG F KIM W H et aL IFN-gamma/ STAT 1 acts as a proinflamrnatory signal in T cell-media- ted hepatitis via induction of multiple chemokines and ad- hesion molecules 2004Am J Physiol Gastrointest Liver Physiol2004,287,:1
13Multiple Risk Factor Intervention Trial: Risk factor changes and motality results显示文摘Multiple Risk Factor Intervention Trial Research Group 2012JAMA2012,24,8:1
14PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS显示文摘PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group and the University of British Columbia MS/MR1 Analysis Group 2001Neurology2001,56,12:1
15A report on two cases 显示文摘Selroos O van Assendelft A Thrombocythaemia and multiple myeloma 1977Acta Med Scand1977,201,3:1
16Randomised double-blind placebo-controlled study of interferon beta-la in relapsing/remitting multiple sclerosis 显示文摘PRISMS ( Prevention of Relapses and Disability by Interferon beta-la Subcutaneously in Multiple Sclerosis ) Study Group 1998Lancet1998,352,9139:1
17Can they predict outcome? 显示文摘Giannoudis PV Hildebrand F Pape HC Inflammatory serummarkers in patients with multiple trauma 2004J Bone Joint Surg Br2004,86,3:1
18Multiple Risk Factor Intervention Trial:risk factor changes and mortality results显示文摘Multiple Risk Factor Intervention Trial Research Group 0,,12:1
19The Rochester-Toronto MRI Study Group 显示文摘Schiffer RB Giang DW Mushlin A et aL Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis 1993J Neuroimaging1993,3,2:1
20Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial显示文摘IFN-β Multiple Sclerosis Study Group University of British Columbia MS/MR1 Analysis Group 1995Neurology1995,45,7:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费